Usefulness of QVARTMfor the Treatment of Bronchial Asthma—With and Without Use of an Inhalation Device
Authors:
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 43 (8) , 613-618
Abstract
The treatment of bronchial asthma with QVAR (hydrofluoroalkane-134a BDP; 3M Pharmaceuticals, St. Paul, MN, USA) is usually conducted without an inhalation assistance device. However, Japanese patients who experience difficulty in coordinating activation with inspiration of inhaled steroid drugs are instructed on the use of such a device. We therefore examined the necessity of using an inhalation assistance device (INSPIR-EASE, IE) and its effect on quality of life (QOL) in the treatment of patients with bronchial asthma taking QVAR. Hence, lung function and QOL associated with taking QVAR plus IE or QVAR alone were examined by a cross-over method in 44 bronchial asthma patients (STEP 2 or 3) over 20 years of age. In all patients, lung function tests conducted 12 weeks after start of treatment indicated significant improvements of forced expiratory volume in 1 second (FEV1) with QVAR alone compared with QVAR plus IE (p < 0.05). In patients less than 70 years of age, significant improvements of forced vital capacity (FVC) and nitric oxide (NO) were also observed with QVAR alone compared with QVAR plus IE (p < 0.05). Examination of QOL the Living with Asthma Questionnaire indicated that medication usage was significantly improved with QVAR alone compared with QVAR plus IE. Significant improvement of FEV1 was observed with QVAR alone compared with QVAR plus IE, and additionally in patients less than 70 years of age improvement of FVC and NO was also marked. This study confirmed the usefulness of QVAR alone in patients with bronchial asthma.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of the Responsiveness of Different Disease-Specific Health Status Measures in Patients with AsthmaChest, 2002
- Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasoneEuropean Respiratory Journal, 1998
- Fluticasone Propionate Improves Quality of Life in Patients with Asthma Requiring Oral CorticosteroidsAnnals of Allergy, Asthma & Immunology, 1996
- Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmaticsQuality of Life Research, 1994
- Quality of Life in Asthma. I. Internal Consistency and Validity of the SF-36 QuestionnaireAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax, 1992
- The Living with Asthma QuestionnaireRespiratory Medicine, 1991
- A scale for assessing quality of life in adult asthma sufferersJournal of Psychosomatic Research, 1991
- Effect of InspirEase on the Deposition of Metered-Dose Aerosols in the Human Respiratory TractChest, 1986
- The Sickness Impact Profile: Development and Final Revision of a Health Status MeasureMedical Care, 1981